Pharmaceutical company to pay $12.9M to settle Texas Medicaid fraud claim

An India-based multinational pharmaceutical manufacturer has agreed to pay $12.9 million to settle claims it reported inflated prices to the Texas Medicaid program, the Texas attorney general said June 8. 

Advertisement

Dr. Reddy’s Laboratories alleged inflated price-reporting began in October 2003, according to the settlement agreement. The company denies wrongdoing.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.